Trial Profile
A Prospective, Randomized, Open-label, Multi-center, Controlled Clinical Trial of the Safety and Efficacy of Physiological Iron Maintenance in End Stage Renal Disease (ESRD) Subjects by Delivery of Soluble Ferric Pyrophosphate (SFP) Via Hemodialysate
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2015
Price :
$35
*
At a glance
- Drugs Ferric pyrophosphate (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 19 Nov 2014 New trial record